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Abstract
Background: Venous Thromboembolism (VTE) is a cause of hospital mortality and managing its morbidity is
associated with significant expenditure. Uptake of evidenced based guideline recommendations intended to
prevent VTE in hospital settings is sub-optimal. This study was conducted to explore clinicians’ attitudes and the
clinical environment in which they work to understand their reluctance to adopt VTE prophylaxis guidelines.
Methods: Between February and November 2009, 40 hospital employed doctors from 2 Australian metropolitan
hospitals were interviewed in depth. Qualitative data were analysed according to thematic methodology.
Results: Analysis of interviews revealed that barriers to evidence based practice include i) the fragmented system
of care delivery where multiple members of teams and multiple teams are responsible for each patient’s care, and
in the case of VTE, where everyone shares responsibility and no-one in particular is responsible; ii) the culture of
practice where team practice is tailored to that of the team head, and where medicine is considered an ‘art’ in
which guidelines should be adapted to each patient rather than applied universally. Interviewees recommend clear
allocation of responsibility and reminders to counteract VTE risk assessment being overlooked.
Conclusions: Senior clinicians are the key enablers for practice change. They will need to be convinced that
guideline compliance adds value to their patient care. Then with the support of systems in the organisation
designed to minimize the effects of care fragmentation, they will drive practice changes in their teams. We believe
that evidence based practice is only possible with a coordinated program that addresses individual, cultural and
organisational constraints.
Background
Health systems around the world are under financial
pressure and reform measures are intensifying. Such
measures often emerge as efforts to standardise clinical
practice. Evidence based Clinical Practice Guidelines are
being used increasingly as a strategy for achieving con-
sistency across clinical areas and within practice. While
there is increasing evidence of patient benefit from the
utilisation of Clinical Practice Guidelines, clinician
adherence and implementation remains poor and the
failure to change clinician behaviour with the implemen-
tation of guidelines has been demonstrated in many
areas of healthcare [1-3].
One such example of poor compliance with guidelines
relates to the prevention of venous thromboembolism
(VTE) for hospitalised patients. VTE manifests as deep
vein thrombosis (DVT) and/or pulmonary embolism
(PE). It spans hospital specialties and is usually inciden-
tal to the problem with which a patient presents to hos-
pital. Nonetheless, the consequences of VTE are
substantial. VTE contributes to as many as 10% of hos-
pital deaths [4-6]. In addition, it is associated with sig-
nificant morbidity from recurrent thrombotic events,
post thrombotic syndrome (characterised by debilitating
leg pain, swelling and fibrosis, and in severe cases, leg
ulcers [7]) and pulmonary hypertension [8]. As such
VTE results in major socioeconomic decrements in
terms of family disruption and loss of time in the work-
force for these patients. In Australia annual VTE asso-
ciated costs, including the costs associated with
premature death, are said to be as much as 0.15% of the
Gross Domestic Product [9]. Effective prevention of
VTE will save lives, improve patient outcomes and
reduce healthcare costs.
* Correspondence: beng.chong@unsw.edu.au
† Contributed equally
1St George Public Hospital, Kogarah, NSW, Australia
Full list of author information is available at the end of the article
Chapman et al. BMC Health Services Research 2011, 11:240
http://www.biomedcentral.com/1472-6963/11/240
© 2011 Chapman et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Prevention of VTE for hospitalised patients is rela-
tively easy and inexpensive. Evidence based guidelines
(e.g. [10,11]) and Government policies (e.g. [12]) advo-
cate risk stratification screening of patients and the use
of thromboprophylactic medications (daily or twice daily
sub-cutaneous injections of anticoagulants) or mechani-
cal devices (e.g. wearing graduated compression stock-
ings) for high risk patients for the period of their
hospitalisation. However, large international audits have
shown that thromboprophylaxis is not consistently
applied by clinicians in hospital practice: only 39% of
‘high-risk’ medically ill patients and 58% of ‘high-risk’
surgical patients were receiving appropriate prophylaxis
[6,13,14].
A number of strategies have been tried to improve
risk assessment and thromboprophylaxis implementa-
tion. Like implementation strategies for numerous other
guidelines [3], the strategies used for VTE prophylaxis
guideline implementation have included education pro-
grams, computer and human reminder programs, audits
and feedback. However, like other guideline implemen-
tation studies none have been overwhelmingly successful
in achieving clinician behaviour change, and even the
most successful usually fail to achieve sustainable
change over time [15].
Grimshaw et al. [3] recommend that effective guide-
line implementation requires exploration of clinician
practice and behaviour. Therefore, the aim of this study
was to i) identify doctors’ attitudes towards VTE pro-
phylaxis; ii) understand the clinical environment in
which VTE prophylaxis is implemented, and thus try to
elucidate the barriers to clinicians implementing VTE
Clinical Practice Guidelines and obtain stakeholder
input and ideas so that appropriate strategies for prac-
tice change can be developed.
Methods
Exploratory descriptive study methods [16] using face to
face semi-structured interviews were implemented to
understand attitudes and the clinical environment sur-
rounding the application of VTE Clinical Practice
Guidelines for hospitalised patients.
Study setting and population
The study sites chosen were two tertiary referral hospi-
tals in Sydney, Australia. Both sites are located within
one area health service and are metropolitan based.
Data was collected between February 2009 and August
2009 at the first hospital (n = 34 interviews), and in
August 2009 at the second (n = 6 interviews). The inter-
views undertaken at the second hospital were intended
to confirm or counter findings from the first site and
thus to clarify whether the findings may have been insti-
tution specific. At the time of the study both hospitals
had policies in place recommending VTE and bleeding
risk assessment of all patients admitted. Both hospital
policies list potential VTE risk factors and as per the
recommendations of the Australian and New Zealand
(ANZ) guidelines that were current at the time [17]
recommend that in the presence of any VTE risk factor
that VTE prophylaxis be implemented: chemical prophy-
laxis in the absence of bleeding risk factors and mechan-
ical prophylaxis in all other patients. Both hospitals have
haematologists with particular research interests in VTE
and the main hospital has a history of VTE education
sessions at Grand Rounds and a year prior to the cur-
rent study had participated in a study with multiple edu-
cation interventions intended to improve VTE
prophylaxis [18].
A convenience sample of doctors working within both
hospital sites at the time of the study were eligible to
enrol. Representation was sought from a variety of med-
ical and surgical specialties although Paediatrics, Radiol-
ogy, Dermatology and Mental Health clinicians were
excluded from the study due to there being few patients
at high risk of VTE and thus few who need prophylaxis
in these therapeutic areas.
Junior doctors (Interns and Registrars (JMO)) were
enrolled at different stages within their medical training.
They were randomly selected using the hospital database
paging system. Those who answered their page were
provided with a study description and invited to take
part at a location and time of their convenience. Senior
doctors (both physicians and surgeons) recruited for the
study and were initially invited by email. Recruitment
continued until new interviews were generating no new
themes i.e. data saturation was achieved.
Interview tool
Fourteen semi-structured open-ended questions (in a
format recommended by Creswell and Clark [19]) were
designed to explore clinicians’ opinions, knowledge,
beliefs and usage of Clinical Practice Guidelines. The
questionnaire (see table 1) was designed to be non-lead-
ing with deliberate exclusion of key words. All inter-
views were conducted by a researcher independent of
the hospital and its staff. Questions were conveyed in a
casual conversational manner in order to establish rap-
port. This approach allowed respondents to express
their opinions and ideas freely without bias or pre-con-
ceived ideas imposed by the investigators.
Ethics
The study was approved by both hospitals’ Human
Research Ethics Committees as well as that of the Uni-
versity of New South Wales. All participants gave writ-
ten informed consent for their interview to be recorded
and analysed. All data was de-identified and remained
Chapman et al. BMC Health Services Research 2011, 11:240
http://www.biomedcentral.com/1472-6963/11/240
Page 2 of 11anonymous for analysis. Data was stored and maintained
within a password protected file.
Data Collection
The interviews were recorded using an Olympus digital
voice recorder (DS-3300) and transcribed verbatim into
Microsoft Word and saved as ‘read only’ files for analy-
sis. Demographic data (including age, current ward,
years of experience, and time working in the current
role) was obtained from each participant at the time of
interview.
Data analysis
Interview data was transcribed by the researcher who
conducted the interviews. Interview transcripts were
then analysed using coding methods described by Cres-
well and Clark [19]. This included line-by-line open
coding where conceptual labels within the transcripts
were developed and then grouped into categories. A
qualitative software program (NVivo™) assisted mana-
ging data files by linking codes and categories, and orga-
nising ideas into main themes. Initial coding of the data
in six transcripts was conducted independently by three
co-investigators. The coding was then reviewed, ratio-
nales for codes were discussed, and some categories
were changed as a result. After the intra-rater checks
were completed, a single coder completed coding and
analysis of the remaining data.
Results
Forty clinicians from medical and surgical specialties,
and different hierarchical role positions took part in the
study. Details of medical specialities enrolled are repre-
sented in Figure 1. The interview participants’ demo-
graphic data are presented in Table 2. Complete
interviews were conducted with 39 of the 40 intervie-
wees. One interview was incomplete as the participant
was called to a medical emergency and did not wish to
resume the interview. The average interview duration
was 20 minutes. There were no thematic differences
identified in the data collected from the two hospital
sites.
Interviews identified three key themes influencing clini-
cian behaviour and beliefs with respect to VTE Clinical
Practice Guidelines: 1) ‘Guidelines: friends or foe’-clini-
cians’ attitudes about VTE thromboprophylaxis and guide-
lines; 2) ‘Practice Culture’ which describes an environment
in which medical team rejection, adherence or utilisation
of guidelines is driven by team member influence; and 3)
‘Fragmentation of Care’-a major barrier to guideline com-
pliance, VTE risk assessment screening, and implementa-
tion of medication prophylaxis in hospitalised patients.
Table 1 Questions used to direct discussion with doctors to collect information about their attitudes to VTE
prophylaxis and the barriers and facilitators to them adopting VTE Clinical Practice Guidelines
1 When you are presented with a patient with a particular problem how do you ensure the appropriate care is provided and no aspect of care is
overlooked?
2 How are changes or new research findings incorporated into your practice?
3 Some people think there is some variability in the practice of medicine. Why do you think this perception exists? How is consistency of
treatment ensured in your area?
4 In general what do you know and how do you feel about VTE prophylaxis?
5 What influences whether a patient is VTE risk assessed in your ward and who oversees the assessment? What is the process in different parts of
the hospital for a patient receiving or not receiving VTE prophylaxis? What is your role?
6 How often do you check junior staff are doing what you assume should be done and what you have asked to be done?
7 Can you tell me about a particular patient on your ward that is now receiving
i. Anticoagulant prophylaxis?
ii. Mechanical prophylaxis?
iii. Not receiving either?
8 What was it about that patient or their management that has resulted in them receiving or not receiving prophylaxis?
Would you manage medical patients differently to surgical patients with regards to VTE prophylaxis?
9 How have you gained your information and knowledge about VTE prophylaxis?
10 Do you know of anyone who has had poor outcomes because of VTE prophylaxis, or lack thereof? Has it changed your perspective?
11 How do you feel about the way this hospital manages/uses VTE prophylaxis in general?
12 In an ideal world where resources are not an issue how would you ensure VTE prophylaxis is optimized at this hospital? *
13 I will now give you the official guidelines that are endorsed by this hospital, please take a moment to review them. Are you familiar with them?
*
14 Do you have any thoughts on them, on their improvement or otherwise. *
* Questions added after completion of first 8 interviews.
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thromboprophylaxis and the VTE Clinical Practice
Guidelines
Under this theme we describe an attitude which, despite
general support for the VTE prevention guidelines, does
not encourage the changes in clinical behaviour patterns
necessary to adhere to guidelines.
There was a 100% consensus among interviewees that
VTE is a risk hospitalised patients are exposed to, and
that it is worth preventing:
DVT is a common thing, potentially life threatening
and for patient care it’s a good idea [to prevent it].
Interview 43-Junior Medical Officer, Medical ward
There was agreement by participants that current imple-
mentation of VTE prophylaxis medication was either
“good” or “appropriate” in their institutions and most
(62%) were unaware of audit data (locally or internation-
ally) showing the implementation of prophylaxis in hospi-
talised patients is often suboptimal or inappropriate. All
interviewees felt that thromboprophylaxis risk assessment
screening and anticoagulant prescribing was a doctor’s
responsibility and the majority (86%) had some awareness
of the existence of Hospital Clinical Practice Guidelines
for VTE prophylaxis. However, only a few clinicians
reported using the guidelines when they reviewed patients:
Ia c t u a l l yd o n ’t use [guidelines]. I just write up what
Ik n o ww h i c hi sH e p a r i n5 0 0 0B Do rT D S . . .Id o n ’t
know what the guidelines say.I n t e r v i e w4 - J u n i o r
Medical Officer, Medical specialty
It’s a willy nilly approach to each patient. So its “Oh,
this patient is a bit overweight, yeah let’s [prescribe]
Table 2 Demographic data for participants (n = 40)
Characteristic Value
Gender
Female, n (%) 23 (58%)
Age, mean (SD) 33.3 (11.1)
Hospital, n (%)
St. George Hospital 34 (85%)
Prince of Wales Hospital 6 (15%)
Clinical Specialty, n (%)
Medical 26 (65%)
Surgical 14 (35%)
Position, n (%)
Senior Clinician 12 (30%)
Registrar 8 (20%)
Resident Medical Officer/Intern 20 (50%)
Years in current position, mean (SD) 5.4 (7.6)
Abbreviations: SD, Standard Deviation
Figure 1 Data displaying medical and surgical specialties of clinicians interviewed (n = 40).
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well, they’re a bit overweight, but it’s not too bad” and
won’t [prescribe] them [prophylaxis]. You sort of learn
haphazardly who to [treat]. You don’t refer [to] proto-
cols to do it. Interview 34-Registrar, Medical specialty
Participants described how senior clinicians practice
an ‘art of medicine’ which has been defined elsewhere as
the combination of medical knowledge, intuition, experi-
ence and judgement [20]. Clinicians develop preferences
or an ‘art’ towards patient management and treatment
medicine which is considered to take precedence over
guidelines. With respect to VTE prophylaxis, clinicians
reported taking guidelines into consideration but rarely
considered they should or could be applied universally.
Medicine is not a science, it’s an art, so you cannot
implement a protocol to every single patient.I n t e r -
view 14-Registrar, Surgical ward.
Thus senior clinician’s behaviour often intentionally
deviated from guideline practice. Based on their perso-
nal experiences they reported making conscious deci-
sions not to implement evidence based guidelines.
Senior clinicians reportedly were motivated to consider
either applying prophylaxis or withholding prophylaxis
because they wished to prevent litigation or retribution,
or to prevent a past adverse experience when one of
their patients was or was not given VTE prophylaxis.
If anything when VTE prophylaxis is considered, it’s
prescribed in excess of these [Australasian National]
guidelines; a lot of people who are low risk are still
given VTE prophylaxis. I think it’s just defensive
medicine, ‘cause I guess in our minds a person who is
low risk is also not likely to bleed so it’ss a f e rj u s tt o
give them VTE prophylaxis ‘cause then you could
never be accused of not giving VTE prophylaxis if
they had a PE or something. Interview 1- Junior
Medical Officer, Medical ward
You will find that if a consultant has had a particu-
larly severe adverse event from something, they will
be reluctant to use it whereas it might be evidence
based best practice to do so.
Interview 39-Junior Medical Officer, Medical ward
Senior clinicians who had had a patient who suffered
or died from a pulmonary embolism as a result of a lack
of prophylaxis were more likely to be conscientious with
subsequent patients.
If you’re working on the surgical ward and you see
someone get PE and have a bad outcome, you’re
much more vigilant in the future about trying to pre-
vent it.
Interview 43-Junior Medical Officer, Surgical ward
However, a significant number of interviewees seemed
to be overly concerned with their patients being at risk
of bleeding as a result of prophylaxis with anticoagulant
medication (on occasion following experiencing having a
patient with a serious anticoagulant related bleed). They
used this concern as justification for not using anticoa-
gulant medication especially when combined with their
strong desire to do ‘no harm’ to their patients.
Some people use a lot more prophylaxis than I
would. I just think that, well I think that you can
cause harm with it so you should use it evidence
based for a start, it’s got to be high risk, you can
cause harm with [prophylaxis]. Interview 10-Regis-
trar, Surgical ward
I think in the physician group its oversight [of VTE
prophylaxis] and in the surgical group its paranoia. I
think in many cases the fear [of bleeding] is over-
stated particularly in neurosurgery and even more so
in orthopaedics. Interview 23-Senior Clinician, Medi-
cal ward
Contrary to the Australian guideline recommendations
[17] that were in use within both of our institutions, the
majority of interviewees reported that their primary cri-
teria for deciding whether a patient should receive pro-
phylaxis medication or not, was the patient’s mobility or
immobility.
I think immobility is probably the biggest [indica-
tion]. [Patients who] are immobile and have no other
contraindications [will get prophylaxis]. The ones
who are walking [around] might not receive any [pro-
phylaxis]. Interview 14-Registrar, Medical specialty
I think DVT Prophylaxis in some form should be
compulsory for every single patient that presents in to
hospital, even mobile patients. I think that in hospi-
tal people are still much less mobile than when they
are at home or in their work setting. So even if some-
one’sm o b i l et h er e a l i t yi st h e ya r ej u s tp r o b a b l y
mobilising to the toilet and back.
Interview 40-Registrar, Medical specialty
Thus although the majority of interviewees had no
particular concerns with the VTE Prophylaxis Clinical
Practice Guidelines, the prevailing medical behaviour
adhered to ‘adapting practice’ for individual patients
rather than the ‘cook-book’ approach of the Clinical
Practice Guidelines.
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best practice is implemented
Organisational culture is seen as a set of norms, rules,
values, philosophies, attitudes, and meanings distributed
within a group and that manifest in their behaviour and
thus their observable practices [21]. The ‘Culture of
Practice’ described in our interviews was one of a very
hierarchical team environment where senior clinicians
prescribe practices within their teams. Our hospitals as
organisations are an environment in which we saw the
‘community of practice’ described by Fenlie et al. [22]
where one doctor within a team cannot adopt significant
changes to practice without discussion and consent from
colleagues within the team. VTE prophylaxis practice
varied from one ward to another and from one senior
clinician to another. Junior staff reported adapting their
behaviour and practices to that of their current senior
clinician and medical team.
The biggest influence [on my practice] is just what
my seniors do on that term, so my practice would
change from term-to-term depending on what my
seniors do and want.
Interview 26-Junior Medical Officer, Surgical Ward
Yeah, I’ve looked at [the VTE prevention guidelines]
a couple of times, mostly though you just get into a
pattern of what your bosses like and that’s what you
end up doing.
Interview 26-Junior Medical Officer, Surgical ward
However with no consistency of practice and con-
strained by the need to conform with team behaviour
and actions, Junior Medical Officers (JMOs) often lack
the confidence required to apply evidence based
practice.
Thus interviewees identified a team approach that was
focused on shared values and beliefs about practice,
which were largely directed by senior clinicians’ prefer-
ences often despite prevailing evidence. Junior Medical
Officers embraced the team culture modifying their own
behaviour to align it with that of more senior team
members.
Fragmentation of Care: A barrier to evidence based best
practice
’Fragmentation of care’ is used to describe specialty
based medical care which has led to some responsibil-
ities being unclear. Compounding the situation is the
often less than ideal communication between the hospi-
tal team members themselves. Interviewees described
VTE prophylaxis ‘falling through the gaps’ due to over-
s i g h t .I tw a so v e r l o o k e da sf o c u sw a sb e i n gg i v e nt ot h e
presenting illness and treating the medical symptoms
rather than problems that may or may not develop
throughout the hospitalisation.
Well it never is the first priority preventing DVT/PE.
Im e a nt h ef i r s tp r i o r i t yi st os t a b i l i s et h ep a t i e n t
and [manage their] condition and [VTE prophylaxis]
doesn’t come under there, but it should come under
your overall management plan of the patient but it
gets overlooked I think... it’s easy to overlook it. Inter-
view 11-Junior Medical Officer, Medical specialty
You’ve got a patient who has come in with a problem
or a symptom and you’re concentrating on that and
if that isn’t the thromboembolic family, then you’re
not necessarily going to think about [VTE]. Interview
47-Senior Clinician, Emergency Medicine
’Specialisation’ of care was also used to explain VTE
‘blindness’ by staff: clinicians’ practice is focused on pro-
viding medical treatment for particular areas of specialty
rather than holistic patient care. Specialisation contri-
butes towards the fragmentation of care.
You know they are too focused on the heart or the
kidney or whatever it is they are doing to think about
DVT prophylaxis. Interview 23-Senior Clinician,
Medical ward
Generally, there was a lack of consistency about whose
responsibility it was to consider VTE screening and pro-
phylaxis medications. This was in terms of which medi-
cal team speciality was responsible for this intervention,
as well as which member of the medical team should
undertake the screening and write up the medication
order (junior or senior medical staff). Although, there
was consensus that VTE risk assessment should occur
early in a patient’s admission, different medical special-
ties disputed whose role it was to consider VTE screen-
ing and prophylaxis medications. For example, there was
some dispute amongst participants as to whether VTE
screening should be conducted by Emergency staff or by
the admitting medical in-patient team.
There is a bit of confusion in [the Emergency Depart-
ment] about whose job it is to chart the patient’s
med[ication]s, whether it’s the doctor that sees them
in [the Emergency Department] or the admitting
registrar or the team on the ward. Interview 26-
Junior Medical Officer, Surgical ward
Id o n ’t think [VTE prophylaxis] necessarily fits into
my initial responsibility of care. If I’m admitting a
patient directly under the [Senior Clinician], then it
probably does fit under my guides of care, I think it
should be a shared responsibility, not entirely our
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matter of priorities, I think in [the Emergency
Department] ‘c a u s ew ea r ea l w a y su n d e rt i m e[ p r e s -
sure]. Interview 20-Senior Clinician, Emergency
Medicine
Role confusion with respect to thromboprophylaxis
was even more evident when multiple medical teams
were caring for patients, especially when the patient had
been admitted to hospital with multiple co-morbidities.
The following clinicians recount how assumptions with
regards to thromboprophylaxis may lead to patients ‘fall-
ing through the gaps’:
Unfortunately what happens sometimes is a patient
gets admitted under one [Senior Clinician], gets oper-
ated [on] by another; a different registrar comes on
to take care of them on the ward-it’sl i k es o m e o n e
will deal with it, not me. Interview 34-Registrar, Sur-
gical ward
Well one reason is if you’re the second person or
third person to see the patient you might assume
that [VTE prophylaxis] is already there.I n t e r v i e w
11-Junior Medical Officer, Medical ward
After-hours care puts patients at greater risk of being
missed for VTE prophylaxis as hospital staffing numbers
and experience levels are commonly reduced. Partici-
pants identified that lower after-hours staffing and
expertise reduced opportunities to consider VTE risk
and that patients coming into hospital, after-hours,
would often fall through the gaps.
On Monday after the weekend intake, some of the
teams will have 30 or 40 patients to see and they
won’t always get to [review and chart VTE prophy-
laxis]. Interview 27-Junior Medical Officer, Surgical
ward
I think that variability often happens on weekends or
after-hours. [Those] doctors don’ta l w a y sk n o wt h e
story and it’s hard when you’ve got lots of patients to
see and to prioritise... to be honest [after hours] you’d
just see patients who are [really] sick, so I don’t
always check if they are on prophylaxis, I don’t have
the time. Interview 12-Junior Medical Officer, Surgi-
cal Ward
Greater than 25% of participants interviewed who
were part of a medical ward admitting team volunteered
that if VTE prophylaxis was omitted during the initial
phases of a patient’s admission that the omission could
remain unnoticed for several days, or in some cases, for
the remainder of the patient’s hospital stay:
From my experience it’s great if they’re flagged and
charted for prophylaxis at admission. If not, they
tend to sort of get left for a few days before you rea-
lise. You sort of assume it has been addressed and
it’s only later you find out that it hasn’t [been]. Inter-
view 13-Junior Medical Officer, Medical ward
If it’s not remembered at admission then no one
remembers it a week down the track and then its two
weeks down the track and your patient has a PE, so I
think that’s one problem.
Interview 1-Junior Medical Officer, Medical ward
In addition to a lack of clarity between medical teams,
there was no clarity about who is responsible within a
team for VTE risk assessment. Although, with the
exception of one, all senior clinicians interviewed felt
that VTE prophylaxis management could be delegated
to junior staff members.
Mostly in my ward [VTE prophylaxis is] not my duty
but the duty of the junior... medical officers.I n t e r -
view 2-Senior Clinician, Medical ward
However, it appeared that junior doctors infrequently
initiate VTE prophylaxis without direction.
It was my first term and I felt like I was too junior to
be deciding what-I wasn’t confident in prescribing
VTE prophylaxis. Interview 26-Junior Medical Offi-
cer, Surgical ward
I’m not sure that as a new intern [they will] put
someone on prophylaxis unless the registrars tell
them to. Interview 14-Registrar, Surgical ward
Thus in a time poor environment with multiple teams
and multiple clinicians within the teams contributing to
the care of an individual patient, the cross functional
responsibility of VTE implementation and management
is susceptible to being overlooked.
Strategies suggested to improve evidence based practice
Acknowledging that VTE is not a priority, the intervie-
wees repeatedly highlighted how time poor they were
when reviewing individual patients. Thus for VTE risk
assessment screening to be incorporated into everyday
practice, it needs to be easy to implement, and imple-
mented in some sort of routine way. Interviewees
recommended that there should be simple reminders
that could be used as a record of risk assessments hav-
ing been completed.
[Risk assessment] should just be part of the standard
chart like the allergy form is...
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It’s probably best to assign one person... someone at
the ward level who checks it for everyone.
Interview 2-Senior Clinician, Medical ward
I guess it depends on making it a habit. Interview 3-
Junior Medical Officer, Medical ward
I think [it should be] in the chart... like a DVT pro-
phylaxis little box and that way you could also
mark, “no DVT prophylaxis” and a bit [of informa-
tion on] why [it’s omitted] so that if the situation
changes or any new teams come into the picture they
know why you’ve chosen not to [prescribe]. Interview
13-Junior Medical Officer, Medical ward
Ideally you would have a DVT clinical nurse consul-
tant who went around and looked at every med
chart. I think a human reminder is still the best.
Interview 16-Senior Clinician, Medical ward
I think the opt-out system is the best and in an ideal
world there would be some type of automatic alert
system whereby if a patient is admitted to the ward
a certain number of things have to be checked off on
a computer as part of that admission. Interview 33-
Senior Clinician, Medical ward
Interviewees suggested a sticker in the medical charts
may be an appropriate prompt for staff to undertake
VTE screening. Interestingly, our primary study site uses
a prompting sticker system. A recent medical record
audit we conducted identified that all patients had the
bright blue prompt sticker in the notes. However, few if
any of the stickers had been completed.
Discussion
Guidelines are intended to ‘improve quality of care by
decreasing inappropriate variation and expediting the
application of effective advances to everyday practice’[2].
Adoption of VTE prevention guidelines is expected to
save lives, improve patient outcomes and reduce health-
care costs. Nonetheless, like many areas of healthcare
[1,23], adoption of VTE prevention guidelines is subop-
timal [13,14]. This study gathers information about clin-
ician attitudes and the clinical environment in which
clinicians are working and establishes that the barriers
to implementing Clinical Practice Guidelines for VTE
prophylaxis are multi-factorial. It is not surprising there-
fore that single approaches to improving VTE preven-
tion are rarely effective [15]. However as recommended
in practice change literature [22,24-28], having identified
the barriers, multilevel and systematic strategies for
changing practice can be proposed.
The attitudes towards VTE prophylaxis and the guide-
lines that were elucidated in the interviews suggest that
in the first instance individual clinicians need to be con-
vinced that change is necessary. Clinicians need to know
how their practice differs from guideline recommenda-
tions and then they need to believe that changing to
guideline recommendations will improve outcomes for
their patients. The majority of our interviewees believed
that VTE prophylaxis was well implemented in their
hospital. This is contrary to what is observed interna-
tionally [13,14], but also contrary to audit data collected
coincidentally at the primary study site (unpublished
data) where we found 36% of patients at high risk for
VTE are overlooked for prophylaxis during their hospi-
talisation. A traditional audit and feedback approach
could well address this barrier to guideline adoption.
More difficult to address is the need to convince clini-
cians that following the guideline recommendations will
be in their patient’s best interests. The current environ-
ment in Australia promotes the use of VTE prophylaxis
in hospitalised patients: the National Health and Medi-
cal Research Council has identified VTE prevention as a
priority area for improving patient safety and has gener-
ated national guidelines [11] and State Health Depart-
ments are preparing policies to enforce risk assessment
and VTE prophylaxis implementation. The result of this
activity is perhaps the heightened awareness evident in
the interview data of VTE as a condition of importance
and a condition worth preventing. However although, all
our interviewees knew guidelines existed, and 98%
expressed an opinion consistent with support for VTE
prevention guidelines, clinicians, particularly those
managing medical patients, considered that the guide-
lines were not intended to be applied universally but
more to act as a guide for adapting practice to indivi-
dual patients (’the art of medicine’). We found personal
experiences rather than guidelines dominate practice
behaviour, beliefs and values. Instead of referring to
guidelines to guide clinical decision making and prac-
tice, each clinician’s practice is based on their experien-
tial knowledge gained and continually updated and
amended during their education, conferences, discus-
sions with colleagues and management of individual
patients. Gabbay and LeMay [29] describe this acquisi-
tion of knowledge for applying to medical practice as
developing ‘mindlines’ rather than guidelines. This was
evident by interviewees exaggerating the bleeding risks
associated with anticoagulants at prophylactic doses and
exaggerating immobility as a VTE risk factor, and by the
variations in team practice described by junior doctors.
If guideline directed care for VTE prophylaxis is going
to be embraced by clinicians, there has to be clear evi-
dence that its implementation will add benefit to their
current practice for patients.
Perhaps it is time to alter traditional approaches to
rolling out Clinical Practice Guidelines. Like the major-
ity of evidence based guidelines, guidelines for VTE risk
assessment and prophylaxis application are based on
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very nature include only a select group of patients
[30,31], and guidelines are an extrapolation from these
select groups to broader population groups. For example
Tapson et al. [32] report that less than 12% of real
world medical patients fulfil VTE prophylaxis clinical
trial inclusion criteria. Although, VTE prevention guide-
lines are generally accepted and advocated [10,33,34]
within the medical community, they are not completely
without controversy because of the clinical trials upon
which they are based [35,36]. If a research study demon-
strated that consistent application of VTE guidelines
results in an improvement in clinical outcomes (in this
case less deep vein thrombosis, pulmonary embolism,
and bleeding events) as well as being cost effective,
would senior clinicians be sufficiently motivated to
switch to a ‘cookbook’ a p p r o a c h ?I ti sa na p p r o a c ht o
rolling out treatment guidelines that has yet to be tried
at least in VTE prophylaxis.
Sustainable changes to clinical practice need to be dri-
ven and championed by individuals. As our exploration
into the clinical environment suggested, to encourage a
culture of evidence based practice within health care
systems, senior clinician support is critical. The partici-
pants in our study describe a culture where there is
already very little variation within a team (the senior
clinician leading the team prescribes the practice of the
clinicians within the team). The social context of prac-
tice is autonomous and hierarchical with junior staff
altering their behaviour to reflect that of their current
team’s senior clinician. It is one which fosters a team
approach and fosters consistency within that team. In
this way organisational culture can be remoulded. In the
case of VTE prophylaxis, our results suggest that if
senior clinicians’ practice is consistent with guidelines,
members of their teams will follow suit.
However the clinical environment we described was
also one of competing priorities. VTE risk crosses all
medical specialties and as such needs to be considered
for nearly every patient admitted to hospital. Even with
the best intentions, with the multitudes of competing
priorities when a patient is first admitted to hospital,
and with the inherent care fragmentation of multiple
teams and multiple members of teams looking after
each patient, it is regularly overlooked. Role confusion
within teams, and between teams, was a recurring
theme and is consistent with the findings of Cook et al.
[37] who postulate that the intra- and multidisciplinary
care inherent in hospital patient management, results in
unclear role accountability. The World Health Organisa-
tion listed communication during patient care handover
as one of its ‘high 5’ patient safety initiatives to improve
continuity, safety and ultimately the outcome of care
[38]. Interviewees reported that communication between
teams about whether risk assessment had been done
was lacking. The lack of adequate documentation adds
to role responsibility confusion- who in the team as well
as which team should be managing VTE prophylaxis?
Role responsibility needs to be clarified across the
organisation and systems need to be implemented to
facilitate documentation and handover communication
in the fragmented system of care functioning in hospi-
tals today. VTE prophylaxis is more consistently applied
to surgical patients than medically ill patients [14]. Since
the incidence of VTE in untreated patients varies little
between medical and surgical patients [10], the differ-
ence may be due to the fact that the importance of VTE
prophylaxis for surgical conditions has been supported
for a much longer period of time. It may be related to
t h ef a c tt h a tV T Eg u i d e l i n e sa r em o r ec o n s i s t e n ta n d
easier to apply in the surgical patient cohort. Alterna-
tively, it may be related to its routine consideration and
charting as part of the pre-operation work up for the
patient. By having guidelines embedded in structural
processes and clearly articulating role responsibilities
with regards to VTE risk assessment and prophylaxis
implementation, it seems it is more likely to be consid-
ered and appropriately prescribed.
The fact that clinicians do not routinely refer to
guidelines, that they are time poor and have many com-
peting priorities, suggests that tools to address the frag-
mented care present must be simple and effective.
These could take the form of reminders (e.g. computer
alerts or human reminders or less sophisticated paper
cues (e.g. lists and stickers)). Kucher et al [39] have
demonstrated that a computer alert on electronic medi-
cal records decreased the occurrence of DVT and PE by
41% compared to patients whose doctors were not
prompted for VTE prophylaxis with an electronic-
reminder [39,40]. In the absence of suitable technology,
having a dedicated VTE prophylaxis support position
such as a nurse practitioner within a hospital has been
demonstrated to improve prophylaxis rates by up to
48% [18,40].
Thus the attitudes of doctors to VTE prevention and
evidence based practice with respect to VTE prevention,
and clinical environment in which VTE prevention is
implemented, suggest that like the change theories of
Grol and Grimshaw [27], changing current practice with
respect to VTE prevention will need to incorporate a
multilevel approach taking into consideration the indivi-
dual doctors, the social context in which they work as
well as the organisational context.
Conclusion
The complexity and drivers of clinical behaviour and
decision making provides a significant challenge to the
implementation of evidence based practice guidelines in
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Page 9 of 11our health system. However patient outcomes can be
enhanced through the utilisation of evidence based prac-
tice guidelines and the best possible approach to
improving patient outcomes associated with VTE is a
coordinated program that addresses individual, cultural
and organisational constraints.
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